[go: up one dir, main page]

NO20030454D0 - Sammensetning og fremgangsmåte for å forsterke elastisiteten til vev - Google Patents

Sammensetning og fremgangsmåte for å forsterke elastisiteten til vev

Info

Publication number
NO20030454D0
NO20030454D0 NO20030454A NO20030454A NO20030454D0 NO 20030454 D0 NO20030454 D0 NO 20030454D0 NO 20030454 A NO20030454 A NO 20030454A NO 20030454 A NO20030454 A NO 20030454A NO 20030454 D0 NO20030454 D0 NO 20030454D0
Authority
NO
Norway
Prior art keywords
composition
tissue elasticity
enhancing tissue
enhancing
elasticity
Prior art date
Application number
NO20030454A
Other languages
English (en)
Norwegian (no)
Other versions
NO20030454L (no
Inventor
Thomas F Mitts
Lawrence B Sandberg
Jr Felipe Jimenez
Original Assignee
Connective Tissue Imagineering
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/580,110 external-priority patent/US6809075B1/en
Priority claimed from US09/580,893 external-priority patent/US6794362B1/en
Priority claimed from US09/580,156 external-priority patent/US6962904B1/en
Priority claimed from US09/584,001 external-priority patent/US6506731B1/en
Application filed by Connective Tissue Imagineering filed Critical Connective Tissue Imagineering
Publication of NO20030454L publication Critical patent/NO20030454L/no
Publication of NO20030454D0 publication Critical patent/NO20030454D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20030454A 2000-05-30 2003-01-29 Sammensetning og fremgangsmåte for å forsterke elastisiteten til vev NO20030454D0 (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US09/580,110 US6809075B1 (en) 2000-05-30 2000-05-30 Elastin peptide analogs and uses of same incombination with skin enhancing agents
US09/580,893 US6794362B1 (en) 2000-05-30 2000-05-30 Asparagine containing elastin peptide analogs
US09/580,156 US6962904B1 (en) 1998-03-13 2000-05-30 Elastin peptide analogs and uses thereof
US09/584,001 US6506731B1 (en) 1998-03-13 2000-05-30 Elastin peptide analogs and methods of using same
PCT/US2001/017384 WO2001091700A2 (fr) 2000-05-30 2001-05-30 Composition et procede destine a ameliorer l'elasticite des tissus

Publications (2)

Publication Number Publication Date
NO20030454L NO20030454L (no) 2003-01-29
NO20030454D0 true NO20030454D0 (no) 2003-01-29

Family

ID=27504943

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030454A NO20030454D0 (no) 2000-05-30 2003-01-29 Sammensetning og fremgangsmåte for å forsterke elastisiteten til vev

Country Status (7)

Country Link
EP (1) EP1392346A4 (fr)
AU (2) AU7501801A (fr)
CA (1) CA2415225A1 (fr)
IL (1) IL153687A0 (fr)
NO (1) NO20030454D0 (fr)
NZ (1) NZ523403A (fr)
WO (1) WO2001091700A2 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2827170B1 (fr) * 2001-07-13 2004-07-16 Soc Extraction Principes Actif Utilisation de peptides pour augmenter l'adhesion cellulaire
US20030134781A1 (en) * 2001-10-05 2003-07-17 Procyte Corporation Methods for the treatment of hyperpigmentation of skin
EP1434561A1 (fr) * 2001-10-05 2004-07-07 Procyte Corporation Compositions de soins de la peau contenant des complexes peptidiques au cuivre, du retinol, des derives de retinol ou un melange de ces derniers
US20040138103A1 (en) * 2002-11-07 2004-07-15 Procyte Corporation Compositions containing peptide copper complexes and metalloproteinase inhibitors and methods related thereto
DE10260928A1 (de) * 2002-12-20 2004-07-08 Henkel Kgaa Verfahren zur Bestimmung von Markern humaner Gesichtshaut
US6927205B2 (en) * 2003-04-28 2005-08-09 Procyte Corporation Compositions and methods for treatment of psoriasis
FR2854897B1 (fr) * 2003-05-12 2007-05-04 Sederma Sa Compositions cosmetiques ou dermopharmaceutiques pour reduire les signes du vieillissement cutane.
US20060018851A1 (en) * 2004-06-28 2006-01-26 Procyte Corporation Methods and compositions for preventing and treating hyperpigmentation of skin
US20090111758A1 (en) 2006-05-15 2009-04-30 Valio Ltd. Use of therapeutically useful peptides
WO2008100789A2 (fr) 2007-02-16 2008-08-21 Benaroya Research Institute At Virginia Mason Compositions et procédés pour modifier l'élastogenèse
WO2012109561A2 (fr) 2011-02-11 2012-08-16 The Regents Of The University Of Michigan Compositions peptidiques et procédés de traitement de patients
MX2013010977A (es) 2011-03-31 2013-10-30 Procter & Gamble Sistema, modelos y metodos para identificar y evaluar agentes dermoactivos eficaces para tratar la caspa/dermatitis seborreica.
US9920357B2 (en) 2012-06-06 2018-03-20 The Procter & Gamble Company Systems and methods for identifying cosmetic agents for hair/scalp care compositions
AU2020368789B2 (en) 2019-10-16 2024-01-18 Naturesense Co., Ltd. Peptide for improving memory and preventing or alleviating cognitive impairment, composition containing same and preparation method therefor
FR3116273B1 (fr) * 2020-11-17 2023-10-27 Sederma Sa Tétrapeptides, compositions les comprenant et leur utilisation cosmétique
KR102484277B1 (ko) * 2021-11-22 2023-01-04 대한켐텍 주식회사 피부 미용 개선용 원료 조성물의 제조방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4877805A (en) * 1985-07-26 1989-10-31 Kligman Albert M Methods for treatment of sundamaged human skin with retinoids
DE19715103A1 (de) * 1997-04-11 1998-10-15 Targor Gmbh Metallocen-Aminosäure- und Peptid-Komplexe
CA2287254A1 (fr) * 1997-04-21 1998-10-29 Schering Corporation Cytokines de mammifere; reactifs et procedes connexes
US6069129A (en) * 1998-03-13 2000-05-30 Mrs, Llc Elastin derived composition and method of using same
EP1054677B1 (fr) * 1998-11-19 2008-10-22 Connective Tissue Imagineering LLC Utilisation cosmetique ou dermatologique de steroides 7-hydroxylates seuls ou combines ave des peptides derives de l'elastine
PT2275554E (pt) * 1999-10-29 2015-06-26 Novartis Vaccines & Diagnostic Péptidos antigénicos de neisseria

Also Published As

Publication number Publication date
WO2001091700A2 (fr) 2001-12-06
WO2001091700A8 (fr) 2003-11-20
NO20030454L (no) 2003-01-29
IL153687A0 (en) 2003-07-06
NZ523403A (en) 2005-04-29
AU7501801A (en) 2001-12-11
EP1392346A4 (fr) 2006-10-25
AU2001275018B2 (en) 2008-04-03
EP1392346A2 (fr) 2004-03-03
CA2415225A1 (fr) 2001-12-06

Similar Documents

Publication Publication Date Title
NO20030454D0 (no) Sammensetning og fremgangsmåte for å forsterke elastisiteten til vev
DK1339292T3 (da) Sammensætning og fremgangsmåde
NO20023693L (no) Anordning og fremgangsmåte for å tilveiebringe innhold
NO20000847D0 (no) Elastiske brønnsementsammensetninger og fremgangsmåter
NO20013393D0 (no) Brönnsementeringsfremgangsmåter og sammensetninger
ATE510555T1 (de) Chemisch modifizierte neue erythropoietin- stimulierende protein zusammensetzungen und verfahren
NO20013356L (no) Forsinkede tiksotropiske sementsammensetninger og fremgangsmåter
NO20022622L (no) Fremgangsmåte for å tilveiebringe innhold, innretning for å tilveiebringe innhold, og brukerutstyr
NO20022334L (no) Ny sammensetning og anvendelse
NO973046L (no) Elastiske brönnsementsammensetninger og fremgangsmåter
NO973048L (no) Elastiske brönnsementsammensetninger og fremgangsmåter
DK1242095T3 (da) Antimikrobielle sammensætninger og fremgangsmåder til anvendelse deraf
DK1372686T3 (da) Fremgangsmåder og sammensætninger til peptidsyntese
DE60130836D1 (de) Architektur und Verfahren zur Kontextumschaltung
NO20006604D0 (no) Fremgangsmåter og transdermale sammensetninger for lindring av smerte
NO20031848L (no) Polyuretan elastomer gel isolerende sammensetning og anvendelse derav
DK1949936T3 (da) Sammensætning til kontrolleret frigivelse og fremgangsmåde til fremstilling deraf
NO20033854D0 (no) N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
NO20015764L (no) Fremgangsmåte og preparat for å maskere mineralsmak
NO20042012L (no) Sammensetning og fremgangsmate for behandling av diabetes
NO20030843L (no) Anordning og fremgangsmåte for kultivering
NO20014793D0 (no) Selektiv nettverksjuks og fremgangsmåte for å utföre selektiv nettverksjuksing
NO20022057L (no) Fremgangsmåte og sammensetning for å behandle lungesykdommer
NO20005763L (no) DHEA-sammensetning og fremgangsmåte
AU1931602A (en) Cement-containing compositions and method of use

Legal Events

Date Code Title Description
RE Reestablishment of rights (par. 72 patents act)
FC2A Withdrawal, rejection or dismissal of laid open patent application